France: Beware the impact of corporate restructuring on licences

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

France: Beware the impact of corporate restructuring on licences

Trade mark and patent licence agreements generally include provisions regarding the transferability of the agreement to third parties.

Such agreements are frequently concluded in consideration of the person of the licensor or the licensee and include clauses providing that any transfer is subject to the prior consent of either party.

It is also very common that companies and groups of companies be affected by reorganisation or change in capital control which may involve mergers or an equivalent procedure unique to France (called TUP) consisting of the dissolution of a company further to the collection of all the capital shares in hands of its only shareholder. Both procedures involve the complete transfer of all the assets (including IP rights) and debts of the prior company to the surviving company.

Companies are used to thinking about the consequences of the transfer on their IP rights portfolio but rarely about the consequences on their licence agreements.

In this case decided on April 14 2016 by the Paris Court of First Instance, the licensee realised its mistake too late.

Laguiole Licences SAS granted a licence to Koox on the trade marks Laguiole and Bee design for manufacturing and selling cooking devices. It was stated in the agreement, signed on June 1 2011, that the licence was finalised in consideration of the person of the licensee and was not transferable without the prior written consent of the licensor.

On June 22 2012 Koox was dissolved further to the collection of all capital shares in the hands of its only shareholder Der Grune, to which all the assets and debts of Koox were thereby transferred.

Koox did not pay the royalties due further to the agreement and the licensor claimed for this payment, first with Der Grune as successor in title to Koox, and then before the Court.

Der Grune filed the action before the Court for obtaining the termination of the licence agreement, considering it was still the licensee in accordance with the licence granted to Koox.

The Court held that the licence agreement was terminated at the date of dissolution of Koox since it was conditioned by the person of the licensee and since the consent of the licensor was not sought. As a consequence, the agreement was not transferred to Der Grune.

Accordingly Der Grunewas not admitted to act as a licensee by the Court.

However Der Grune acquired the debts of Koox further to the dissolution and the Court held that the unpaid royalties had to be paid by Der Grune to the licensor.

This decision applies to cases of merger of companies as well as to any IP rights.

In addition it should be kept in mind that the company that is no longer a licensee has become an infringer.

rousset.jpg

Nathalie Rousset


Gevers & Ores41, avenue de FriedlandParis 75008, FranceTel: +33 1 45 00 48 48Fax: +33 1 40 67 95 67paris@gevers.euwww.gevers.eu

more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article